Supreme Court Rebuffs Solicitor General, Takes LabCorp Case

Law360, New York (October 31, 2005, 12:00 AM EST) -- Despite a recommendation from the Bush administration urging it not to hear the case, the U.S. Supreme Court has decided to consider a patent infringement suit covering technology that predicts heart attacks, strokes, and dementia.

The suit was filed by Competitive Technologies licensee Metabolite Inc. against Laboratory Corporation, alleging LabCorp infringed a CTT patent for homocysteine assays instrumental in predicting the medical conditions.

Last month, the U.S. Solicitor General recommended to the U.S. Supreme Court that LabCorp’s appeal be denied.

LabCorp filed the petition for a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.